Malin Corporation | Srodki Pieniężne I Ekwiwalent



Cash And Equivalent Zmiana Data
Alaunos Therapeutics USD 1.68M 780K 2024-09
ALKERMES USD 291.15M 636.63M 2024-12
Avita Medical AUD 14.05M 3.4M 2024-12
Dianthus Therapeutics USD 22.79M 10.88M 2024-12
Eurofins Scientific SE EUR 613.9M 67.3M 2024-12
Ionis Pharmaceuticals USD 242.08M 92.53M 2024-12
IQVIA Holdings USD 1.7B 130M 2024-12
Lonza CHF 1.11B 286M 2024-12
Malin Corporation EUR 35.7M 6.4M 2024-06
Moderna USD 1.93B 283M 2024-12
Organon & Co USD 675M 88M 2024-12
Revvity USD 1.16B 66.38M 2024-12
Tectonic Therapeutic USD 141.24M 17.86M 2024-12
Viatris USD 734.8M 1.14B 2024-12
Xeris Pharmaceuticals USD 71.62M 12.39M 2024-12



Malin Corporation Srodki Pieniężne I Ekwiwalent - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Apr 2025.